HealthCare Africa News, December 1 2022

AFRICAN NEWS HEADLINES

• Uganda extends Ebola lockdown, manages its spread

UGANDA –?The government of Uganda has extended a six-week lockdown on two districts at the epicenter of an Ebola outbreak that has claimed 55 lives but said its spread was being curbed?. . .?Read More

• WHO renames Monkeypox to mpox

AFRICA –?WHO will begin using a new preferred term “mpox” as a synonym for monkeypox following a report of racist and stigmatizing language online, in other settings and in some communities?. . .?Read More

• Merck, African First Ladies to end infertility stigma among women

AFRICA –?Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted their annual conference along with African First Ladies of 13 Countries to build healthcare capacity, support girl education and break the infertility stigma?. . .Read More

• NHIF signs contract with KUTRRH

KENYA –?KUTRRH has signed a contract with NHIF to enable all NHIF beneficiaries including National Scheme beneficiaries to enjoy an array of comprehensive benefits?. . .Read More

• KEMRI launches clean energy research initiative

KENYA –?KEMRI has collaborated with the University of Liverpool to launch a new clean energy research initiative to address the burden of non-communicable diseases caused by household air pollution in sub-Sahara Africa?. . .?Read More

GLOBAL?NEWS HEADLINES

• Cyber-attack derails AIIMS Delhi services

INDIA —?All India Institute of Medical Sciences (AIIMS) Delhi has faced a heavy cyber-attack that derailed routine health services and affected thousands of patients?. . .?Read More

• AstraZeneca bolsters oncology portfolio with Neogen buy

UNITED KINGDOM —?AstraZeneca is set to acquire biotechnology company Neogene Therapeutics for up to US$320 million, in the company's latest investment in its oncology offering?. . .?Read More

• Novel drug combination for uncomplicated malaria progresses to Phase 3 trials

SWITZERLAND —?As the threat of resistance to current malaria treatments grows, Novartis and Medicines for Malaria Venture (MMV) have decided to advance ganaplacide/lumefantrine-solid dispersion formulation (SDF) into Phase 3 development for the treatment of acute uncomplicated malaria?.?. .?Read More

• Pakistan launches nationwide anti-polio drive amid rising cases

PAKISTAN —?Pakistani authorities have launched the sixth nationwide anti-polio immunization drive amid a spike in new cases among children?.?. .Read More

• Apollo Cancer Center advances in non-invasive surgery

INDIA —?Apollo Cancer Centre has become the first hospital to perform minimally invasive surgery to remove facial nerve schwannoma on a 35-year-old patient who was suffering from right-sided facial weakness for the last two years?.?. .Read More